Annual Retained Earnings
$111.50 M
+$35.64 M+46.98%
31 December 2022
Summary:
Eagle Pharmaceuticals annual retained earnings is currently $111.50 million, with the most recent change of +$35.64 million (+46.98%) on 31 December 2022. During the last 3 years, it has risen by +$27.02 million (+31.97%). EGRX annual retained earnings is now at all-time high.EGRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$122.42 M
+$5.16 M+4.40%
30 June 2023
Summary:
Eagle Pharmaceuticals quarterly retained earnings is currently $122.42 million, with the most recent change of +$5.16 million (+4.40%) on 30 June 2023. EGRX quarterly retained earnings is now at all-time high.EGRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EGRX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +32.0% | +49.2% |
| 5 y5 years | +91.6% | +71.2% |
EGRX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.0% | at high | +61.4% |
| 5 y | 5 years | at high | +91.6% | at high | +76.5% |
| alltime | all time | at high | +204.1% | at high | +211.6% |
Eagle Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $122.42 M(+4.4%) |
| Mar 2023 | - | $117.25 M(+5.2%) |
| Dec 2022 | $111.50 M(+47.0%) | $111.50 M(+7.9%) |
| Sept 2022 | - | $103.34 M(-6.5%) |
| June 2022 | - | $110.47 M(-7.9%) |
| Mar 2022 | - | $119.92 M(+58.1%) |
| Dec 2021 | $75.86 M(-10.2%) | $75.86 M(-7.6%) |
| Sept 2021 | - | $82.06 M(-6.4%) |
| June 2021 | - | $87.68 M(+4.3%) |
| Mar 2021 | - | $84.07 M(-0.5%) |
| Dec 2020 | $84.49 M(+16.5%) | $84.49 M(+10.5%) |
| Sept 2020 | - | $76.43 M(+10.2%) |
| June 2020 | - | $69.37 M(-0.4%) |
| Mar 2020 | - | $69.63 M(-4.0%) |
| Dec 2019 | $72.50 M(+24.6%) | $72.50 M(+1.4%) |
| Sept 2019 | - | $71.50 M(-3.2%) |
| June 2019 | - | $73.89 M(+10.0%) |
| Mar 2019 | - | $67.16 M(+15.4%) |
| Dec 2018 | $58.19 M | $58.19 M(+27.6%) |
| Sept 2018 | - | $45.60 M(+44.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $31.56 M(+9.2%) |
| Mar 2018 | - | $28.90 M(+10.0%) |
| Dec 2017 | $26.28 M(-202.4%) | $26.28 M(+52.8%) |
| Sept 2017 | - | $17.20 M(+872.8%) |
| June 2017 | - | $1.77 M(-164.6%) |
| Mar 2017 | - | -$2.73 M(-89.3%) |
| Dec 2016 | -$25.66 M(-76.0%) | -$25.66 M(-69.1%) |
| Sept 2016 | - | -$82.96 M(-12.6%) |
| June 2016 | - | -$94.91 M(-12.1%) |
| Mar 2016 | - | -$108.01 M(+0.8%) |
| Dec 2015 | -$107.11 M(+2.8%) | -$107.11 M(-1.1%) |
| Sept 2015 | - | -$108.33 M(+10.4%) |
| June 2015 | - | -$98.16 M(+9.1%) |
| Mar 2015 | - | -$89.99 M(-18.0%) |
| Dec 2014 | - | -$109.68 M(+5.3%) |
| Sept 2014 | -$104.18 M(+2.0%) | -$104.18 M(+9.6%) |
| June 2014 | - | -$95.07 M(+3.2%) |
| Mar 2014 | - | -$92.14 M(-13.5%) |
| Dec 2013 | - | -$106.52 M(+4.3%) |
| Sept 2013 | -$102.14 M(+6.9%) | -$102.14 M |
| Sept 2012 | -$95.54 M | - |
FAQ
- What is Eagle Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Eagle Pharmaceuticals?
What is Eagle Pharmaceuticals annual retained earnings?
The current annual retained earnings of EGRX is $111.50 M
What is the all time high annual retained earnings for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual retained earnings is $111.50 M
What is Eagle Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of EGRX is $122.42 M
What is the all time high quarterly retained earnings for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly retained earnings is $122.42 M